Journal of radiological science and technology (대한방사선기술학회지:방사선기술과학)

Korean Society of Radiological Science (대한방사선과학회)
권호 표지
DOI QR코드

DOI QR Code

Usefulness of Balloon-type Hemostatic Device After Transarterial Chemoembolization

간동맥 화학색전술 후 풍선형 지혈기구의 유용성

  • Received : 2019.06.18
  • Accepted : 2019.06.20
  • Published : 2019.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Transarterial chemoembolization is one of the most representative procedures for puncture of the femoral artery. In addition, the same procedure is often repeatedly performed many times, and Hepatocellular carcinoma patients due to cancer is significantly lowered blood tests, regardless of platelet counts are not good enough to stop bleeding. More importantly, hepatocellular carcinoma has a high degree of complication and disease severity, which makes it less likely that the condition of the body will be relatively inferior to other patients. In order to prevent delayed hemorrhage of the femoral artery puncture site after the procedure, it is advised to absolutely stabilize the limb so that it does not bend the limb for 3 hours after climbing in the ward. Therefore, I have been complaining about inconvenience. In addition, in order to prevent delayed hemorrhage after hemostasis, balloon type hemostatic device was used instead of sand bag which was placed on hemostatic site. The results of this study were compared with the results of actual application. The use of a balloon-type hemostatic device to increase the effectiveness of continuous hemostasis and to minimize the inconvenience during the time of patient's absolute bed rest, rather than raising the sandbag to prevent primary delayed hemorrhage by various methods in transarterial chemoembolization. It can be used as a substitute for existing sand bags because it can alleviate pain, increase satisfaction, and can be used as a disposable one.

Keywords

References

  1. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, Nakajima Y, Ohnishi K. Natural history of hepatocellular carcinoma and prognosis in relation to treatment: Study of 850 patients. Cancer. 1985;56(4):918-28. https://doi.org/10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E
  2. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. A study of 100 untreated cases. Cancer. 1984;54(7):1461-5. https://doi.org/10.1002/1097-0142(19841001)54:7<1461::AID-CNCR2820540740>3.0.CO;2-7
  3. Nagasue N, Yukaya H, Ogawa Y, Sasaki Y, Chang YC, Niimi K. Clinical experience with 118 hepatic resections for hepatocellular carcinoma. Surgery. 1986;99:694-701.
  4. Gozzetti G, Mazziotti A, Cavallari A, et al. Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis. Surg Gynecol Obstet. 1988;166:503-10.
  5. Chen NF, Hwang TL, Jeng LB, Jan YY, Wang CS, Chou FF. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg. 1989;124:1025-8. https://doi.org/10.1001/archsurg.1989.01410090031006
  6. The Liver Cancer Study Group fo Japan. Survey and follow up study of primary liver cancer in Japan. Acta Hapatol Japonica. 1979;20:433-41. https://doi.org/10.2957/kanzo.20.433
  7. The Liver Cancer Study Group fo Japan. Primary liver cancer in Japan. Cancer. 1987;60:1400-11. https://doi.org/10.1002/1097-0142(19870915)60:6<1400::AID-CNCR2820600639>3.0.CO;2-W
  8. Shammas NW, Rajendran VR, Alldredge SG, et al. Randomized comparison of Vasoseal and Angioseal closure devices in patients undergoing coronary angiography and angioplasty. Catheter Cardiovasc Interv. 2002;55:421-5. https://doi.org/10.1002/ccd.10098
  9. Applegate RJ, Grabarczyk MA, Little WC, et al. Vascular closure devices in patients treated with anticoagulation and IIb/IIIa receptor inhibitors during percutaneous revascularization. J Am Coll Cardiol. 2002;40:78-83. https://doi.org/10.1016/S0735-1097(02)01924-1
  10. Michalis LK, Rees MR, Patsouras D, et al. A prospective randomized trial comparing the safety and efficacy of three commercially available closure devices (Angioseal, Vasoseal and Duett). Cardiovasc Intervent Radiol. 2002;25:423-9. https://doi.org/10.1007/s00270-002-1942-9
  11. Weyman RM, Safian RD, Portway V, Skillman JJ, McKay RG, Baim DS. Current complications of diagnostic and therapeutic cardiac catheterization. J Am Coll Cardiol. 1988;12:1400-6. https://doi.org/10.1016/S0735-1097(88)80002-0
  12. Pompa JJ, Satler LF, Pitchard AD, et al. Vascular complications after balloon and new device angioplasty. Circulation. 1993;88: 1569-78. catheterzation. Catheter Cardiovasc Interv. 2001; 53:209-12. https://doi.org/10.1161/01.CIR.88.4.1569
  13. Lee SH, Hahn ST, Park SH. Intraarterial lidocaine administration forrelief of pain resulting from transarterial chemoembolization of hepatocellularcarcinoma: its effectiveness and optimal timing of administration. Cardiovasc Intervent Radiol. 2001;24:368-71. https://doi.org/10.1007/s00270-001-0073-z